Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O4VW
|
|||
| Former ID |
DNCL001819
|
|||
| Drug Name |
TAL-0500018
|
|||
| Synonyms |
Human plasma-derived fibrinolysin
Click to Show/Hide
|
|||
| Indication | Peripheral arterial disease [ICD-11: BD4Z; ICD-10: I73, I73.9] | Phase 2 | [1] | |
| Peripheral arterial occlusive disorder [ICD-11: BD4Z; ICD-10: I73, I73.9; ICD-9: 434.91] | Phase 2 | [2] | ||
| Stroke [ICD-11: 8B20; ICD-10: I64] | Phase 1/2 | [2] | ||
| Company |
Talecris Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021318) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.